Anzemet and Rheumatoid arthritis - a phase IV clinical study of FDA data
Summary:
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Anzemet?
Anzemet has active ingredients of dolasetron mesylate. Currently, eHealthMe is studying from 2,603 Anzemet users.
What is Rheumatoid Arthritis?
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints) is found to be associated with 2,830 drugs and 2,038 conditions by eHealthMe. Currently, we are studying 1,046,716 people who have Rheumatoid arthritis.
Do you take Anzemet and have Rheumatoid arthritis?
Check whether Rheumatoid arthritis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Anzemet side effects by duration, gender and age:
- Anzemet side effects (2,603 reports)
Rheumatoid arthritis treatments and more:
- Rheumatoid arthritis (1,046,716 reports)
All the drugs that are associated with Rheumatoid arthritis:
All the conditions that are associated with Rheumatoid arthritis:
How the study uses the data?
The study uses data from the FDA. It is based on dolasetron mesylate (the active ingredients of Anzemet) and Anzemet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Atenolol and Zoledronic drug interaction - 24 seconds ago
- Propecia and Topamax drug interaction - 26 seconds ago
- Voltaren and Lip And/Or Oral Cavity Cancer - 29 seconds ago
- Finasteride and Nitrofurantoin drug interaction - 29 seconds ago
- Potassium Citrate and Pulmicort drug interaction - 46 seconds ago
- Famvir and Systemic Sclerosis (Scleroderma) - 48 seconds ago
- Colistimethate Sodium and Tri-Sprintec drug interaction - 51 seconds ago
- Focalin Xr and Remeron drug interaction - 55 seconds ago
- Isosorbide Mononitrate and Deep Venous Thrombosis - a minute ago
- Finacea and Urinary Tract Infection - a minute ago